Business Wire

Developing Telecoms Believes China Already Has the Ability to Mass Produce 28nm Chips

11.11.2020 14:00:00 EET | Business Wire | Press release

Share

Developing Telecoms learnt from Li Ke from China Semiconductor Industry Association (CSIA) that the race of chips and the manufacturing of equipment is on to develop home grown solutions, and China already has a presence in the key areas which needed to move toward mid-to-high-end chip production. Li Ke believes that Chinese 28nm chips which can meet most of the market demand will be mass produced in one or two years.

Last year, China's IC industry generated over CNY750 billion and this is expected to reach CNY900 billion in 2020. Shared by Li Ke, IC manufacturing has made the greatest progress among the entire IC industry. China's IC production capacity last year was more than 20% of the world total, larger than any other single country. Li Ke thinks that the narrowing gap between China's IC manufacturing and the world-leading technologies is laying a solid foundation for the prominence of its IC industry, and a domestic chip manufacturing industry chain will be emerged with further advanced technologies.

Li Ke also stresses on the importance of producing 28nm chips. As mentioned by Li Ke, 28nm is the dividing line between low to mid-range and mid-to-high end IC manufacturing. Being able to produce 28nm chips means it can meet most of the demand for chips without relying on others.

Chinese government is actively backing for the chip sector. The State Council has issued the document "Several Policies for Facilitating the High-quality Development of the Integrated Circuit Industry and Software Industry in the New Era", which in part outlines new tax incentives for fabs and companies that use 28nm or smaller technologies. Other policies like "qualified integrated circuit projects or enterprises that have operated for more than 15 years shall be exempt from corporate income tax for the first ten years if they employ the 28nm process or more advanced nodes" is also included.

Developing Telecoms believes China already has the ability to mass produce 28nm chips completely on its own. After more than a decade, China has a presence at every part of the 28nm-technology industry chain and every major aspect for the strategic materials. National-level and joint enterprises projects are also advancing in key parts of China's 28nm chip industry chain such as lithography machines.

About Developing Telecoms

Developing Telecoms is the leading online news portal for telecoms in emerging markets, delivering telecommunications news and information for senior management and decision makers at network operators, governments and end users. Developing Telecoms receives 2.2 million yearly page views and gets over 760,000 yearly online visitors. Its weekly emerging markets newsletter has over 40,000 subscribers. Developing Telecoms publishes a range of special reports about telecoms in emerging markets spanning topics including 5G, IoT, Smart Cities and Last Mile Connectivity.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media
Alec Barton
+44 7799 417751
alec@developingtelecoms.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 20:15:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel

Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 17:00:00 EEST | Press release

Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings, assigned on 12 June 2026. Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation of the company’s

Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 16:17:00 EEST | Press release

Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority. According to Gartner, Visionaries "understands where the market

Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 16:15:00 EEST | Press release

Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The valve features the company’s FREE next generation tissue treatment addressing the two main causes of calcification, phospholipids and aldehydes. Its proprietary LANCELOT advanced manufacturing process includes zero-pressure shaping and laser cutting of

Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale9.10.2026 16:00:00 EEST | Press release

Ada, the pioneer in Agentic Customer Experience, today announced it has achieved the Amazon Web Services (AWS) Travel and Hospitality Competency. The designation recognizes Ada as an AWS Partner with demonstrated technical proficiency and proven customer success helping travel and hospitality brands resolve customer issues at scale. Ada joins a select group of 58 AWS Partners holding the competency, and it reflects a shared commitment to helping travel brands deliver service that holds up on their busiest, most unpredictable days. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009673638/en/ Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale "Travel is where agentic customer service gets tested hardest. Demand spikes without warning, policies change by the hour, and customers are often stressed and far from home," said Mike Murchison, CEO and co-founder of Ada. "Our airline and hospitali

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye